A prospective study reveals that individuals with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn disease have a significantly higher risk of developing chronic obstructive pulmonary disease...
Two phase 3 randomized trials evaluated the efficacy of risankizumab in patients with moderately to severely active ulcerative colitis. The results show significantly higher remission rates with...
Researchers conducted a cross-sectional clinical trial with 8920 participants to evaluate whether a multitarget stool RNA test could serve as a noninvasive tool for detecting colorectal cancer, offering an...
The American College of Gastroenterology and Society of Abdominal Radiology release a set of recommendations on the use of radiologic examinations for evaluating gastrointestinal bleeding in patients. ...
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
Researchers compared the health outcomes of adult patients with moderate ulcerative colitis and early advanced therapy initiation with those who delayed their advanced treatment initiation.
The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
